Manufacturer record

USV Private Limited: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

5 batches manufactured by USV Private Limited (Himachal Pradesh) were declared Not of Standard Quality between August 2022 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

5 records linked to USV Private Limited in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
5Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Aug 2022 to Jul 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

5
NSQ batches since 2022
5
Products affected
Dissolution
Most common failure
Jul 2026
Latest alert

Flagged batches per year

2022 · 12023 · 12024 · 22026 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Metformin Hydrochloride Prolonged-Released and Glimepiride Tablets IP 60002727Mfg 2026-03 · Exp 2028-02 The sample does not conform to claim as per Manufacture's Specification with respect to the test for Dissolution of Metformin Hydrochloride.Dissolution CDTL, IndoreCDSCO lab Jul 2026
Glipizide and Metformin Tablets IP (Glynase-MF) 4010026Mfg 2023-11 · Exp 2025-04 Dissolution of GlipizideDissolution CDL KolkataCDSCO lab Jun 2024
GLIPIZIDEAND METFORMIN TABLETS IP 4010026Mfg 2023-11 · Exp 2025-04 The sample does not conform to claim I.P. with respect to the test for Dissolution of GlipizideDissolution CDL KolkataCDSCO lab May 2024
Fenofibrate Capsules IP 200 mg (LIPICARD) 28022587Mfg 2021-11 · Exp 2023-10 DissolutionDissolution CDL KolkataCDSCO lab Nov 2023
Methylcobalamin and Alpha Lipoic Acid Capsules 28021831Mfg 2021-04 · Exp 2023-02 Description and Assay of Alpha Lipoic AcidAssay RDTL GuwahatiCDSCO lab Aug 2022

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.